Spyre Therapeutics, Inc. · NASDAQ:SYRE

Turtle Cameron sold 15,000 Spyre Therapeutics, Inc. shares (Form 4)

Traded Oct 1, 2026 · Filed Oct 2, 2026

On Oct 1, 2026, Turtle Cameron (Director, Chief Executive Officer) sold 15,000 Spyre Therapeutics, Inc. shares at an average US$92.01 for US$1.38M under a trading plan, leaving 537,540 shares. Filed Oct 2, 2026 (Form 4).

Sold
15,000 shares
Price
US$92.01 average (US$89.14 to US$93.91)
Value
US$1.38M
Holding after
537,540 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 1, 2026Common StockSale600US$89.14551,940Direct
Oct 1, 2026Common StockSale2,683US$90.10549,257Direct
Oct 1, 2026Common StockSale2,638US$91.49546,619Direct
Oct 1, 2026Common StockSale3,989US$92.31542,630Direct
Oct 1, 2026Common StockSale4,990US$93.37537,640Direct
Oct 1, 2026Common StockSale100US$93.91537,540Direct

Source

View original at SEC

Related